Global Gut Microbiome Testing Market By End User
Global Gut Microbiome Testing Market By Application
By Application, the market is segmented into 16S rRNA Sequencing, Alzheimer’s disease, Chronic Diarrhea & Constipation, Irritable Bowel Syndrome (IBS), Metatranscriptomics, Multiple sclerosis, Next Generation Sequencing, Obesity, Others, Parkinson’s disease, Rheumatoid arthritis, Saliva Samples, Shotgun Metagenomics, Stool (Fecal) Samples, Type-2 Diabetes, and Ulcerative Colitis (2019–2036)
Data Source: Wantstats Repository
Growth Outlook
- The Global Gut Microbiome Testing Market By Application market is on a steady long-term growth path. Segment value stands at roughly USD 2912 Million in 2026 and is projected to reach USD 5956 Million by 2036 — a gain of about 105% over the forecast period, translating to a CAGR in the high single digits.
- What the regional split looks like (2026): Stool (Fecal) Samples leads, holding roughly 32% of segment value — the single largest regional share. 16S rRNA Sequencing is the second-largest contributor. Shotgun Metagenomics, Irritable Bowel Syndrome (IBS), Ulcerative Colitis, Type-2 Diabetes, Next Generation Sequencing, Chronic Diarrhea & Constipation, Obesity, Metatranscriptomics, Saliva Samples, Rheumatoid arthritis, Others, Multiple sclerosis, Parkinson’s disease and Alzheimer’s disease make up the remainder, in descending order.
- By 2036, Stool (Fecal) Samples alone is expected to reach USD 1854 Million, with 16S rRNA Sequencing at USD 895 Million.
Market Dynamics
Unlock the Full Data
Get This Chart
Access the complete chart and underlying data to support your research, analysis, and business decisions.
Powering the world's best teams.
From next-gen startups to established enterprises.
Get in Touch
Let's work together
support@wantstats.comSee our work in action
Start your data driven journey with us!
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence
Global Gut Microbiome Testing Market By Application



